Skip to content
Screener

Claritev Corporation CTEV Total Liabilities & Equity

Total Liabilities & Equity at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$1.97B-19.9%
UnitedHealth Group logo
UnitedHealth GroupUNH
$309.73B+0.4%
Conduent Incorporated logo
Conduent IncorporatedCNDT
$2.25B-9.8%
Definitive Healthcare Corp. logo
Definitive Healthcare Corp.DH
$496.83M-35.5%
Corvel logo
CorvelCRVL
$689.74M+15.4%
Phreesia logo
PhreesiaPHR
$666.14M+66.4%

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%
EPS (diluted)-$3.49+8.4%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Reported directly by Claritev Corporation in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Claritev Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001793229-26-000067
Line itemJune 30, 2026December 31, 2025
Additional paid-in capital2,410,8312,398,423
Accumulated deficit(2,562,206)(2,429,420)
Accumulated other comprehensive loss(955)(4,172)
Treasury stock - 879,075 and 742,859 shares as of June 30, 2026 and December 31, 2025, respectively(142,236)(138,733)
Total shareholders’ (deficit)/equity attributable to Claritev Corporation(294,564)(173,900)
Non-controlling interests6,7256,725
Total shareholders' deficit(287,839)(167,175)
Total liabilities and shareholders’ deficit$4,763,857$4,888,458

Item 1. Financial Statements

FAQ

What is Claritev Corporation's total liabilities & equity?
Claritev Corporation (CTEV) reported total liabilities & equity of $4.76B in Q2 2026.
How has Claritev Corporation's total liabilities & equity changed year-over-year?
Claritev Corporation's total liabilities & equity decreased by 6.1% year-over-year, from $5.07B to $4.76B.
What is the long-term trend for Claritev Corporation's total liabilities & equity?
Over 5 years (2020 to 2025), Claritev Corporation's total liabilities & equity has grown at a -10.0% compound annual growth rate (CAGR), from $8.28B to $4.89B.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Claritev Corporation's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude